Curiel DT - Search Results

1

Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension.

Reynolds AM, Xia W, Holmes MD, Hodge SJ, Danilov S, Curiel DT, Morrell NW, Reynolds PN. Reynolds AM, et al. Among authors: curiel dt. Am J Physiol Lung Cell Mol Physiol. 2007 May;292(5):L1182-92. doi: 10.1152/ajplung.00020.2006. Epub 2007 Feb 2. Am J Physiol Lung Cell Mol Physiol. 2007. PMID: 17277049 Free article.

2

New generation adenoviral vectors improve gene transfer by coxsackie and adenoviral receptor-independent cell entry.

Reynolds PN, Curiel DT. Reynolds PN, et al. Among authors: curiel dt. Kidney Int. 2002 Jan;61(1 Suppl):S24-31. doi: 10.1046/j.1523-1755.2002.0610s1024.x. Kidney Int. 2002. PMID: 11841608 Free article. Review.

3

A new targeting approach for breast cancer gene therapy using the heparanase promoter.

Breidenbach M, Rein DT, Schöndorf T, Khan KN, Herrmann I, Schmidt T, Reynolds PN, Vlodavsky I, Haviv YS, Curiel DT. Breidenbach M, et al. Among authors: curiel dt. Cancer Lett. 2006 Aug 18;240(1):114-22. doi: 10.1016/j.canlet.2005.09.007. Epub 2005 Nov 3. Cancer Lett. 2006. PMID: 16271435

4

Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector.

Reynolds P, Dmitriev I, Curiel D. Reynolds P, et al. Gene Ther. 1999 Jul;6(7):1336-9. doi: 10.1038/sj.gt.3300941. Gene Ther. 1999. PMID: 10455445

5

The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy.

Crystal RG, Brantly ML, Hubbard RC, Curiel DT, States DJ, Holmes MD. Crystal RG, et al. Among authors: curiel dt. Chest. 1989 Jan;95(1):196-208. doi: 10.1378/chest.95.1.196. Chest. 1989. PMID: 2642408 Review. No abstract available.

6

A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo.

Reynolds PN, Zinn KR, Gavrilyuk VD, Balyasnikova IV, Rogers BE, Buchsbaum DJ, Wang MH, Miletich DJ, Grizzle WE, Douglas JT, Danilov SM, Curiel DT. Reynolds PN, et al. Among authors: curiel dt. Mol Ther. 2000 Dec;2(6):562-78. doi: 10.1006/mthe.2000.0205. Mol Ther. 2000. PMID: 11124057 Free article.

7

Secretin-mediated gene delivery, a specific targeting mechanism with potential for treatment of biliary and pancreatic disease in cystic fibrosis.

McKay T, Reynolds P, Jezzard S, Curiel D, Coutelle C. McKay T, et al. Mol Ther. 2002 Apr;5(4):447-54. doi: 10.1006/mthe.2002.0560. Mol Ther. 2002. PMID: 11945072 Free article.

8

Ribonuclease A cleavage combined with the polymerase chain reaction for detection of the Z mutation of the alpha-1-antitrypsin gene.

Abe T, Takahashi H, Holmes MD, Curiel DT, Crystal RG. Abe T, et al. Among authors: curiel dt. Am J Respir Cell Mol Biol. 1989 Oct;1(4):329-34. doi: 10.1165/ajrcmb/1.4.329. Am J Respir Cell Mol Biol. 1989. PMID: 2624766

9

Chimeric viral vectors--the best of both worlds?

Reynolds PN, Feng M, Curiel DT. Reynolds PN, et al. Among authors: curiel dt. Mol Med Today. 1999 Jan;5(1):25-31. doi: 10.1016/s1357-4310(98)01378-1. Mol Med Today. 1999. PMID: 10088129 Review.

10

Analysis of cell-specific promoters for viral gene therapy targeted at the vascular endothelium.

Nicklin SA, Reynolds PN, Brosnan MJ, White SJ, Curiel DT, Dominiczak AF, Baker AH. Nicklin SA, et al. Among authors: curiel dt. Hypertension. 2001 Jul;38(1):65-70. doi: 10.1161/01.hyp.38.1.65. Hypertension. 2001. PMID: 11463761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters